Search
for
Sort by
Research 331–360 of 788
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- THE USE OF AN IMMUNOMODULATOR WITH AN ANTISEPTIC IN THE TREATMENT OF INFECTED AND PURULENT WOUNDS IN AN EXPERIMENT
- Etiopathogenesis of Alopecia Areata
- Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Alopecia Areata: An Updated Review for 2023
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Nanotechnological reprogramming of the pathological skin microenvironment in scar formation and atopic dermatitis
- Farmácia Padrão da Légua, Custóias e nos Serviços Farmacêuticos da Klinicka Bolnica Dubrava, Croácia
- N6-methyladenosine (m6A)-circHECA from secondary hair follicle of cashmere goats: identification, regulatory network and expression regulated potentially by methylation of its host gene promoter
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Selection signatures of wool color in Gangba sheep revealed by genome-wide SNP discovery
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- 600 Impact of baricitinib on work productivity and indirect costs in adult patients with atopic dermatitis: A meta-analysis of clinical trials
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders